190 related articles for article (PubMed ID: 8571778)
1. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
Wang WG; Wang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
[TBL] [Abstract][Full Text] [Related]
2. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
Liu X; Shang B; Liu X
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of the immunoconjugate composed of antibiotic C1027 and Fab fragment from a monoclonal antibody directed against human hepatoma].
Li JZ; Jiang M; Xue YC; Zhen YS
Yao Xue Xue Bao; 1993; 28(4):260-5. PubMed ID: 8213168
[TBL] [Abstract][Full Text] [Related]
5. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
Li J; Zhen Y; Yang Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
7. [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
Zhang SY; Li S; Chen LJ; Shu YH; Zhang XY; Chen XT
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):556-60. PubMed ID: 2130622
[TBL] [Abstract][Full Text] [Related]
8. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
9. [Experimental studies on therapeutic effect of rat monoclonal antibody-bleomycin A6 conjugate against human colorectal cancer].
Deng YC; Zhen YS; Zheng S; Jiang M
Yao Xue Xue Bao; 1993; 28(6):410-5. PubMed ID: 7504390
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
Liu X; Zhen Y
Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
Wang FQ; Shang BY; Zhen YS
Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
Wang F; Li S; Lin J
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
14. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
16. [Experimental studies on the antitumor activity of monoclonal antibody--bleomycin A6 conjugate against human liver cancer].
Peng Z; Zhen YS
Yao Xue Xue Bao; 1991; 26(5):331-5. PubMed ID: 1720270
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of combined target treatments using PYM-BAC5 and 131I-BAC5 to nasopharyngeal carcinoma].
Liang ZP; Liu CZ; Cheng JY; Xiao XB; Zhang CQ; Liang CS
Ai Zheng; 2003 Aug; 22(8):831-5. PubMed ID: 12917029
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of pingyangmycin on human liver cancer and stomach cancer xenografts in nude mice].
Jiang M
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):357-9. PubMed ID: 2470565
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer.
Apelgren LD; Zimmerman DL; Briggs SL; Bumol TF
Cancer Res; 1990 Jun; 50(12):3540-4. PubMed ID: 2340502
[TBL] [Abstract][Full Text] [Related]
20. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
